Literature DB >> 29458443

Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital-wide oligoclonal outbreak.

V Pérez-Blanco1, L Redondo-Bravo1, G Ruíz-Carrascoso2, J R Paño-Pardo3, R Gómez-Gil2, A Robustillo-Rodela1, J García-Rodríguez2, J Mingorance2, R Herruzo1.   

Abstract

The main objective of our study was to describe the epidemiological and microbiological features of an oligoclonal hospital-wide outbreak caused by OXA-48-producing Enterobacteriaceae (OXA-48-PE). OXA-48 is a carbapenemase belonging to Ambler class D beta-lactamases, identified frequently in the Mediterranean and Southern European countries, and associated with several Enterobacteriaceae species. An outbreak of OXA-48-PE with a complex epidemic pattern was detected in January 2011. Initial control measures included contact precautions and the reinforcement of infection control practices, but despite all efforts made, the epidemiological situation hardly changed and new measures were implemented during 2013. An observational retrospective study was performed to describe the main features of the outbreak and to analyse the cumulative incidence (CI) trends. Eight hundred and 16 patients colonised or infected by OXA-48-PE were identified during the 2-year period (January 2013-December 2014), female 46%, mean age (s.d.), 71.6 (15.2). The samples isolated in the incident cases were rectal swabs (80%), urine samples (10.7%), blood samples (2.8%) and other clinical samples (6.6%). The most frequent OXA-48-PE was Klebsiella pneumoniae. Eleven different clones were identified, but K. pneumoniae sequence types 11 and 405 were predominant: ST11 (64.2%) and ST405 (29.3%). OXA-48-PE CI trend suffered a statistically significant change in August 2013, which continued the following months. Though we could not eradicate the outbreak, we observed a statistically significant drop in CI after an intervention for OXA-48-PE control, based on patient cohort, active surveillance, electronic alerts and reinforcement of infection control measures in a tertiary hospital.

Entities:  

Keywords:  Carbapenem-resistant Enterobacteriaceaezzm321990 ; control measures; epidemiology; outbreak

Mesh:

Substances:

Year:  2018        PMID: 29458443      PMCID: PMC9134566          DOI: 10.1017/S0950268818000249

Source DB:  PubMed          Journal:  Epidemiol Infect        ISSN: 0950-2688            Impact factor:   4.434


  19 in total

Review 1.  An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae.

Authors:  Mitchell J Schwaber; Yehuda Carmeli
Journal:  Clin Infect Dis       Date:  2013-12-04       Impact factor: 9.079

2.  Potential role of active surveillance in the control of a hospital-wide outbreak of carbapenem-resistant Klebsiella pneumoniae infection.

Authors:  Debby Ben-David; Yasmin Maor; Nathan Keller; Gili Regev-Yochay; Ilana Tal; Dalit Shachar; Amir Zlotkin; Gill Smollan; Galia Rahav
Journal:  Infect Control Hosp Epidemiol       Date:  2010-06       Impact factor: 3.254

Review 3.  Risk of infection following colonization with carbapenem-resistant Enterobactericeae: A systematic review.

Authors:  Jessica Tischendorf; Rafael Almeida de Avila; Nasia Safdar
Journal:  Am J Infect Control       Date:  2016-02-15       Impact factor: 2.918

4.  Molecular epidemiology of carbapenemase-producing Klebsiella pneumoniae in a hospital in Madrid: Successful establishment of an OXA-48 ST11 clone.

Authors:  Patricia Brañas; Jennifer Villa; Esther Viedma; Jesús Mingorance; M Angeles Orellana; Fernando Chaves
Journal:  Int J Antimicrob Agents       Date:  2015-04-06       Impact factor: 5.283

Review 5.  The difficult-to-control spread of carbapenemase producers among Enterobacteriaceae worldwide.

Authors:  P Nordmann; L Poirel
Journal:  Clin Microbiol Infect       Date:  2014-09       Impact factor: 8.067

Review 6.  Carbapenemase-producing Enterobacteriaceae: overview of a major public health challenge.

Authors:  P Nordmann
Journal:  Med Mal Infect       Date:  2013-12-18       Impact factor: 2.152

7.  Infections caused by OXA-48-producing Klebsiella pneumoniae in a tertiary hospital in Spain in the setting of a prolonged, hospital-wide outbreak.

Authors:  José Ramón Paño-Pardo; Guillermo Ruiz-Carrascoso; Carolina Navarro-San Francisco; Rosa Gómez-Gil; Marta Mora-Rillo; María Pilar Romero-Gómez; Natalia Fernández-Romero; Julio García-Rodríguez; Verónica Pérez-Blanco; Francisco Moreno-Ramos; Jesús Mingorance
Journal:  J Antimicrob Chemother       Date:  2012-10-07       Impact factor: 5.790

8.  Forecasting carbapenem resistance from antimicrobial consumption surveillance: Lessons learnt from an OXA-48-producing Klebsiella pneumoniae outbreak in a West London renal unit.

Authors:  M Gharbi; L S P Moore; M Gilchrist; C P Thomas; K Bamford; E T Brannigan; A H Holmes
Journal:  Int J Antimicrob Agents       Date:  2015-04-23       Impact factor: 5.283

9.  Carbapenem-resistant Gram-negative bacteria - analysis of the data obtained through a mandatory reporting system in the Rhine-Main region, Germany, 2012-2015.

Authors:  Ursel Heudorf; Barbara Büttner; Anja M Hauri; Petra Heinmüller; Klaus-Peter Hunfeld; Martin Kaase; Niels Kleinkauf; Sabine Albert-Braun; Rolf Tessmann; Volkhard A J Kempf
Journal:  GMS Hyg Infect Control       Date:  2016-04-28

10.  Within-Host and Population Transmission of blaOXA-48 in K. pneumoniae and E. coli.

Authors:  Manon R Haverkate; Mirjam J D Dautzenberg; Tjaco J M Ossewaarde; Anneke van der Zee; Jan G den Hollander; Annet Troelstra; Marc J M Bonten; Martin C J Bootsma
Journal:  PLoS One       Date:  2015-10-20       Impact factor: 3.240

View more
  7 in total

1.  Emergence of Klebsiella pneumoniae Harboring the aac(6')-Ian Amikacin Resistance Gene.

Authors:  Paloma Troyano-Hernáez; Almudena Gutiérrez-Arroyo; Rosa Gómez-Gil; Jesús Mingorance; Fernando Lázaro-Perona
Journal:  Antimicrob Agents Chemother       Date:  2018-11-26       Impact factor: 5.191

Review 2.  Epidemiology of β-Lactamase-Producing Pathogens.

Authors:  Karen Bush; Patricia A Bradford
Journal:  Clin Microbiol Rev       Date:  2020-02-26       Impact factor: 26.132

Review 3.  The Global Ascendency of OXA-48-Type Carbapenemases.

Authors:  Johann D D Pitout; Gisele Peirano; Marleen M Kock; Kathy-Anne Strydom; Yasufumi Matsumura
Journal:  Clin Microbiol Rev       Date:  2019-11-13       Impact factor: 26.132

4.  Dissemination of a single ST11 clone of OXA-48-producing Klebsiella pneumoniae within a large polyclonal hospital outbreak determined by genomic sequencing.

Authors:  Fernando Lázaro-Perona; Elias Dahdouh; Alma Sotillo; Verónica Pérez-Blanco; Jennifer Villa; Esther Viedma; Guillermo Ruiz-Carrascoso; Jesús Mingorance
Journal:  Microb Genom       Date:  2022-04

5.  Proof-of-concept trial of the combination of lactitol with Bifidobacterium bifidum and Lactobacillus acidophilus for the eradication of intestinal OXA-48-producing Enterobacteriaceae.

Authors:  Juan Carlos Ramos-Ramos; Fernando Lázaro-Perona; José Ramón Arribas; Julio García-Rodríguez; Jesús Mingorance; Guillermo Ruiz-Carrascoso; Alberto M Borobia; José Ramón Paño-Pardo; Rafael Herruzo; Francisco Arnalich
Journal:  Gut Pathog       Date:  2020-04-07       Impact factor: 4.181

6.  A hybrid simulation model approach to examine bacterial genome sequencing during a hospital outbreak.

Authors:  Thomas M Elliott; Xing J Lee; Anna Foeglein; Patrick N Harris; Louisa G Gordon
Journal:  BMC Infect Dis       Date:  2020-01-23       Impact factor: 3.090

7.  Epidemiology and control measures of an OXA-48-producing Enterobacteriaceae hospital outbreak.

Authors:  Anand Sivaramakrishnan; Damien Mack; Husam El-Mugamar; Judy Jacques; Stephanie Paget; Lynette Phee; Yvonne Carter
Journal:  Infect Prev Pract       Date:  2020-05-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.